At least two entrepreneurs hope so. Pradeep Gidwani and Rahul Singh, owners of two respective beer cafe chains, want to make the drink as easily available and as widely consumed as coffee in India.
India's drug regulator is getting a makeover but better enforcement and safer medicines are yet a chimera A close look at the Indian pharmaceutical industry shows a complicated regulatory structure and a web of entities at the central and state levels tasked with monitoring the sector. The regulator is now getting a makeover but better enforcement and safer medicines are yet a chimera.
Indian mobile gaming companies change tack to woo the world Finding few takers within the country, Indian mobile gaming companies change tack to woo the world.
Ranbaxy has very high credibility even today: Arun Sawhney Arun Sawhney, MD and CEO, Ranbaxy, defended the company in an interview with Chaitanya Kalbag. Edited excerpts:
Rising royalty payments by Indian subsidiaries worry tax authorities Many multinationals have jacked up royalty rates from local
subsidiaries ever since the Indian government scrapped a cap on
royalties to overseas parents about three years ago. Shareholders say the higher royalty payouts are cutting into
net profits and, in effect, reducing their dividend payouts.
Ranbaxy is not a lemon, it's a fantastic company: Malvinder Singh Fortis Healthcare Executive
Chairman Malvinder Singh, while rebutting Japanese firm Daiichi Sankyo's charges, says the company failed in growing the Ranbaxy business.
Disgraced Ranbaxy has a long way to go before it regains the lost trust The pharma major is still to get its Paonta Sahib and Dewas units back on track
for inspection and approval by the FDA so that it can resume supplies to
the US from these facilities.
Phaneesh Murthy does not have a glad eye but attracts people A glimpse into the working style of India's star IT salesman, who is embroiled in a sexual harassment case for the third time.
FDA has learnt from the Ranbaxy Case: Dinesh S. Thakur Dinesh S. Thakur, who blew the whistle on Ranbaxy's wrongdoings, spoke
over the phone from the US with Chaitanya Kalbag and E. Kumar Sharma.